first_img11:30 a.m.: WHO announces effort to accelerate vaccinesDr. Tedros Adhanom Ghebreyesus, the director general of the World Health Organization, announced that his agency was launching a new effort to accelerate the fight against the virus. Tedros said in a briefing that the effort will bring together health groups and private sector partners to find a vaccine and ensure the public has access to it. “This is a landmark collaboration to accelerate the development, production and equitable distribution of vaccines, diagnostics, and therapeutics for COVID-19,” the director general said.The partnership for the ACT Accelerator includes the help of French President Emmanuel Macron, EU President Ursula von der Leyen and Bill and Melinda Gates.“We are facing a common threat, which we can only defeat with a common approach,” Tedros said.11:08 a.m.: US death toll surpasses 50KThe death toll in the United States has surpassed 50,000, according to data compiled by Johns Hopkins University.There are now at least 50,031 deaths in the country, the data shows.The grim milestone was reached Friday morning, five days after the number of fatalities hit 40,000.The U.S. has the highest death toll in the world and the most number of cases.10:46 a..m: Stay-at-home order extended in MichiganMichigan Gov. Gretchen Whitmer has extended the state’s stay-at-home order through May 15.The order was previously set to end on April 30.The new order will require people to wear homemade, non-medical face coverings when entering enclosed public spaces, such as grocery stores, according to a statement from Whitmer’s office. People will not face criminal penalties for going out without a mask, her office said.Some restrictions will also be eased. Nurseries, landscaping and lawn-service companies can reopen, but social distancing must be maintained, according to Whitmer’s office. Retailers that do not sell necessary supplies will also be allowed to reopen for curbside pick-up and for delivery.Motorized boating and golf will be allowed, but using golf carts is still prohibited. Individuals will also be allowed to travel between their residences, but her office noted that “such travel during the epidemic is strongly discouraged.”“With new COVID-19 cases leveling off, however, we are lifting some of the restrictions put in place in the previous order,” Whitmer said. “I want to be crystal clear: the overarching message today is still the same. We must all do our part by staying home and staying safe as much as possible.”10:31 a.m.: NYC mayor says all COVID metrics are downNew York City Mayor Bill de Blasio on Friday offered what he called “just plain good news” on the virus’s spread in the city.De Blasio said all indicators — hospitalizations, ICU admittances and percent of the population that tested positive — were all down.Daily hospitalizations of people with suspected COVID-19 went down from 227 to 176, which the mayor called a “serious decline.” The number of people admitted to ICUs on a daily basis decreased from 796 to 786 and the citywide percentage of people who tested positive went from 32% to 30%.De Blasio also spoke about the disproportionate ways the virus appears to affect communities of color. His Equity Action Plan includes active testing sites in those communities and advertisements that are broadcasted in 15 languages in 88 zip codes.He said even after the pandemic ends, New Yorkers can never “look away” from these disparities.10:03 a.m.: NY hydroxy trials deliver inconclusive resultsTrials of a malaria drug that was touted by President Donald Trump for treating COVID-19 delivered inconclusive results in New York, according to the head of the research team.There was not a “statistically significant difference” between patients who took hydroxychloroquine and those who did not, David Holtgrave, dean of the University at Albany School of Public Health, told ABC News.During CNN’s coronavirus town hall on Thursday night, New York Gov. Andrew Cuomo backed that up, saying the drug “was not seen as a positive, not seen as a negative.” 8:59 a.m.: South Korea reports no deaths, only six new casesFor the first time in a month, South Korea has reported no new deaths from COVID-19 in the last 24 hours, according to the Center for Disease Control (KCDC). There were also only six new cases as of Friday, the KCDC reported. The total number of confirmed cases in South Korea is at least 10,708, according to data compiled by Johns Hopkins University.7:16 a.m.: Lysol company says don’t ingest its products to fight coronavirusReckitt Benckiser, the company that makes Lysol, said you should not inject or ingest any of its products as a potential treatment for the coronavirus. This statement follows a press briefing Thursday in which President Donald Trump seemed to muse that UV light and disinfectants could maybe combat COVID-19.“We must be clear that under no circumstance should our disinfectant products be administered into the human body (through injection, ingestion or any other route),” the company said in a statement.RB, without specifically mentioning Trump or the press briefing, said it felt compelled to put out a statement because of “recent speculation and social media activity … whether internal administration of disinfectants may be appropriate for investigation or use as a treatment for coronavirus.”“Then I see the disinfectant where it knocks it out in a minute, one minute,” Trump said during Thursday’s White House Coronavirus Task Force briefing. “And is there a way we can do something like that, by injection inside or almost a cleaning because you see it gets in the lungs and it does a tremendous number on the lungs so it would be interesting to check that.”His comments came after a Department of Homeland Security official said their research found that ultraviolet rays and disinfectants like bleach and isopropyl alcohol work well against the virus.6:15 a.m.: Georgia governor defends opening some nonessential businessesGeorgia Gov. Brian Kemp defended his controversial plan to open some nonessential businesses on Friday, despite criticism from President Donald Trump.Kemp said he’s followed federal safety guidelines and that now is the time to start reopening the state’s economy.“Now, with favorable data and approval from state health officials, we are taking another measured step forward by opening shuttered businesses for limited operations,” Kemp tweeted Thursday night. “I know these hardworking Georgians will prioritize the safety of their employees and customers. Together, we will weather this storm and emerge stronger than ever.”Trump said Kemp went too far in opening some of the state’s businesses.“I want him to do what he thinks is right,” Trump said during a press briefing Wednesday. “But … I think (opening) spas and beauty salons and tattoo parlors and barbershops in Phase One … it’s just too soon.”In addition, Kemp released new requirements through executive order, detailing how various businesses can begin reopening again starting on Friday and Monday. Some requirements include that restaurants must post signs saying no one with symptoms of COVID-19 can enter.Georgia has at least 21,883 diagnosed cases of COVID-19, with at least 881 deaths.3:30 a.m.: China reports no new COVID-19 deaths for ninth straight dayChina reported no new deaths from the novel coronavirus for the ninth consecutive day on Friday.There were also only six new cases of COVID-19, two of which were brought into the country from overseas, according to China’s National Health Commission.Since the virus was first detected in the city of Wuhan back in December, the Chinese mainland has reported 82,804 confirmed cases of COVID-19 and 4,632 deaths.Hospitals were still treating 915 patients with confirmed cases as of Friday morning, including 57 who are listed in serious condition, according to the National Health Commission. Copyright © 2020, ABC Audio. All rights reserved. narvikk/iStockBy MORGAN WINSOR, WILLIAM MANSELL and ELLA TORRES, ABC News(NEW YORK) — A pandemic of the novel coronavirus has now killed more than 190,000 people worldwide.Over 2.7 million people across the globe have been diagnosed with COVID-19, the disease caused by the new respiratory virus, according to data compiled by the Center for Systems Science and Engineering at Johns Hopkins University. The actual numbers are believed to be much higher due to testing shortages, many unreported cases and suspicions that some governments are hiding the scope of their nations’ outbreaks.Since the first cases were detected in China in December, the United States has become the worst-affected country, with more than 869,000 diagnosed cases and at least 50,031 deaths. Here’s how the news is developing Friday. All times Eastern:last_img read more

first_imgThe UK government has confirmed its intention to retain the Food Standards Agency (FSA), though a number of its former policy areas will become the responsibility of other government departments.This follows a report in The Guardian last week, which stated that the FSA was set to be abolished and its responsibilites divided up in Whitehall.These claims were downplayed at the time by government, which said that the FSA’s role would be reviewed in a public health paper due this autumn.It has now announced its plans ahead of schedule, with the Department of Health gaining responsibility for nutrition policy in England, including front-of-pack labelling, such as Guideline Daily Amounts. However, the FSA will retain its responsibility for nutrition and labelling policy in Scotland, Wales and Northern Ireland.The Department for Environment, Food and Rural Affairs (Defra) will take country of origin labelling under its wing, along with various other non-safety-related food labelling and food composition policies in England. This will leave a drastically scaled-down FSA focusing solely on food safety policy and enforcement.The FSA will support the delivery of the government’s commitment to deliver honesty in food labelling, and the delivery of one of Defra’s top priorities: the commitment to support and develop British farming and encourage sustainable food production, and promote increased domestic food production.The government said it was keen for food safety policy, the primary focus of the FSA when it was established as a non-ministerial Government department in 2000, to remain independent.The changes have been made with the aim of contributing to “objectives to improve efficiency”, as well as improving the health of the nation.“It’s absolutely crucial for the Food Standards Agency to continue providing independent expert advice to people about food safety. But bringing nutrition policy into the Department makes sense,” commented secretary of state for health Andrew Lansley. “It will enable a clear, consistent public health service to be created, as our Public Health White Paper later this year will set out.”The Food & Drink Federation has welcomed today’s announcement. “We believe it is important to maintain an independent food safety regulator and fully support today’s decision by the government to retain the Food Standards Agency,” commented director general Melanie Leech.“We also support the decision to move responsibility for nutrition, and other food policy issues, back into government departments. This should lead to clearer and more consistent policy-making, while avoiding unnecessary duplication of effort across Whitehall.”>>Question mark on FSA leaves bakers in limbolast_img read more

first_imgCrowdsourcing, the act of contracting out problems to large groups rather than tapping individual experts, has solved puzzles in fields such as marketing, engineering, and computer software. But can the wisdom of crowds help cure disease?A large, multidisciplinary panel has recently selected 12 pioneering ideas for attacking type 1 diabetes, ideas selected through a crowdsourcing experiment called the “Challenge,” in which all members of the Harvard community, as well as members of the general public, were invited to answer the question: What do we not know to cure type 1 diabetes?“We wanted to ask the entire Harvard community — faculty, students, and administrators and staff of all levels and specialties — to share their ‘out of the box’ questions and proposals for this challenge, regardless of whether they had the expertise or resources to answer the question,” said Harvard Catalyst Director and Harvard Medical School (HMS) Dean for Clinical and Translational Research Lee Nadler. “We wanted the participants to apply their insights to a problem that may not have been in their academic or intellectual domain.”Among the authors of the winning ideas are a patient, an undergraduate student, an M.D./Ph.D. student, a human resources representative, and researchers who are not experts in the field.Out of 190 entries, 12 were chosen. Each of the winners, who were formally announced in a ceremony held at Harvard Medical School on Sept. 28, will receive a prize of $2,500. Working with the Leona M. and Harry B. Helmsley Charitable Trust, Harvard Catalyst plans to solicit research proposals from within the Harvard research community on some or all or the winning questions.In a letter to the Harvard University community at the Challenge’s launch in February, Harvard President Drew Faust expressed her hope that “such broad outreach will help stimulate innovative thinking and potential new understandings and therapies,” wishing that “in the spirit of this novel project, we will continue to multiply the means to connect the remarkable people and ideas across Harvard in imaginative and powerful ways.”Apart from the potentially revolutionary submissions from the community, the Challenge, in which Harvard collaborated with InnoCentive, provides evidence that finding new and innovative ideas for tackling disease is itself an act of innovation. “The Challenge was an exercise in tapping the knowledge of the widest possible community and encouraging the formation of new teams and new forms of collaboration around a specific topic area,” said Dana-Farber Cancer Institute’s Eva Guinan, director of the Harvard Catalyst Linkages program and one of the Challenge’s co-leaders.According to research by Challenge co-leader Karim Lakhani, an assistant professor at Harvard Business School, innovation contests like this one can help reveal and foster unexpected and novel solutions to vexing scientific problems. “Open innovation is an effective way to solve scientific problems in the business world.”The Challenge was part of an American Recovery and Reinvestment Act (ARRA)-funded effort by Harvard Catalyst and InnoCentive to investigate whether new approaches employed in the private sector for sparking new research directions and collaborations might be useful in the academic health care community.The winners and their ideas Anonymous: The Diabetes Triangle: A Systematic Approach to Align Diabetes Classification with Diabetes Management A new way of looking at diabetes by the numbers. Is there a better way of classifying diabetes than “type 1” and “type 2?” This winner, a patient with an uncommon form of diabetes and who wished to remain anonymous, thinks there is: A new scale — the Diabetes Triangle — that would use three simple measures to classify diabetes in a much more fine-grained, personalized way. This easy-to-use scale would help patients, and their doctors, better understand their disease and the steps they need to take to control it.Megan Blewett: Lipid Autoreactivity in Type 1 Diabetes: Clue to Etiology, Co-occurrence, and Drug Discovery Diabetes Chemistry 101. Even though diabetes medications are essentially chemicals, we don’t know much about the chemistry underlying the development of diabetes. Harvard College undergraduate chemistry major Blewett suggests that studying diabetes — and in particular how, in the context of diabetes, the immune system interacts with molecules called lipids — from a chemical perspective could yield new insights into the diabetic process and new strategies for treatment.“I first heard about the Challenge through the campuswide email sent by President Faust,” said Blewett ’11. “I was drawn to the fact that the challenge promised to create a dialogue spanning scientific disciplines and based on the merit of people’s ideas. Opportunities like this are extremely rare.Kevin Dolan: Type 1 Diabetes, Patient Maintenance and Care Keeping a constant eye on blood sugar. The current crop of implanted insulin pumps do their job by keeping constant track of the amount of glucose in the fluids that bathe our cells, a kind of proxy method for tracking blood sugar. Dolan, who works in Human Resources at HMS and who has type 1 diabetes, suggests that a new generation of pumps that sample blood sugar directly could help improve patients’ quality of life and blood sugar control, consequently bringing overall health care costs down.“Type 1 diabetes is a complicated disease that requires one to be thinking constantly about what he/she eats, what his/her exercise level has been or needs to be, what his/her blood sugar level is at, and knowing if it rising or falling,” said Dolan. “Despite all that, it is not a disease that prevents someone from being successful in whatever endeavor they choose to pursue. I felt providing the perspective to Challenge of someone who deals with type 1 diabetes on a daily basis would help researchers as they pursue improved diabetes care management and eventually a cure.”Mark Feinberg: Synergistic System Targeting for Type I Diabetes Taking a multipronged approach. Which is better: to treat the root causes of diabetes from one direction at a time, or from multiple directions at once? Feinberg favors the latter. He suggests that a better understanding of how different parts of the immune system affect the pancreas in diabetes would allow for the development of tools capable of targeting those parts simultaneously.“I had two recent ‘jolts’ that motivated me to take part in the contest,” said Feinberg, a cardiologist at Brigham and Women’s Hospital. “First, I recently had a patient with long-standing type 1 diabetes who, despite his and his doctors’ best efforts, was suffering the end-stage effects of his disease. The second was the news that a very young family member of mine had just been diagnosed with type 1 diabetes. This prompted me to think about my own research endeavors and whether some of the things I’ve been studying could be applicable to this disease.”David Friedman: A Quiet Role for Platelets and Eosinophils in Pathogenesis of Type 1 Diabetes?Roles for other immune cells in diabetes? The discussion about immunity in type 1 diabetes usually focuses on T cells. But the immune system has many, many more components. Beth Israel Deaconess Medical Center nephrologist Friedman wants to know whether these other parts, including, for example, cells and proteins involved in the body’s response to allergens and parasites, might also play roles in the development of diabetes.“In thinking about the Challenge, I wanted to connect immunity and autoimmunity through the lens of genetics,” Friedman explained. “These are ideas that would generally be considered too speculative for funding through typical channels.”Jason Gaglia: In-depth Analysis of T Cell Repertoire During the Development of Type 1 Diabetes in Pancreatic Islet Infiltrating and Peripheral CD4 T Cells The T cell as a window on diabetes development. What can immune system T cells tell us about the origins of diabetes? Gaglia, an endocrinologist in the Pathology Department at HMS, suggests quite a bit. He proposes using T cells in the blood as a view into what’s going on in the pancreas of patients with diabetes. This approach could help lead to new, targeted treatments, or to ways of measuring whether treatments are working.“The Challenge gave me an opportunity to think globally about approaches to diabetes, as opposed to the niche my research has focused on,” Gaglia commented. “It has helped me explore aspects of my field and related fields that are removed from my current research.Danwei Huangfu: A Cell-Electronic Approach to Insulin Therapy Merging biology and engineering. Where should we look for the next generation of blood sugar monitors? Our own bodies. Eons of evolution have fine-tuned our beta cells to sense blood sugar levels and secrete insulin accordingly, in precisely the right amounts. Huangfu, a postdoctoral fellow at Harvard University, proposes linking beta cells of the pancreas to an electronic insulin pump, establishing a new paradigm for diabetes control.“I am preparing to start my own laboratory, and looked at the Challenge as an opportunity to identify novel research directions,” said Huangfu. “But I realized that my own research had become more focused on the cells destroyed by diabetes than on the disease itself. Thinking through my submission has, in the end, made me more conscious of Type 1 diabetes as a disease.”Carlos Mendivil Anaya: Integral Treatment of Type 1 Diabetes Using Smart Liposomes Make “smart” treatments for diabetes. The current methods of taking diabetes medications — by mouth or by injection — allow these drugs to spread throughout the body. Mendivil Anaya, an endocrinologist from Colombia in a doctoral program at the Harvard School of Public Health, suggests using microscopic spheres (called “smart liposomes”) studded with proteins that can dial down the immune attack against the beta cells in people with type 1 diabetes to carry drugs directly to the pancreas, giving them extra targeted punch.“I have seen the trials and tribulations of many type 1 diabetes patients as they moved from childhood into adolescence and adult life,” said Mendivil Anaya. “This has made the human face of diabetes very familiar and very close to my heart.”Matthew Meyerson, Sally Kent, David Hafler, Joonil Jung, Alex Kostic, and Akinyemi I. Ojesina: Hunting for Microbial Genomes in Type 1 Diabetes by Next-Generation Sequencing A germ theory for diabetes. Viruses like to leave little bits of genetic baggage behind. This team of researchers from the Broad Institute of Harvard and MIT, Dana-Farber Cancer Institute, the University of Massachusetts Medical Center, and Yale School of Medicine sought to find out whether viruses or other microbes might play some part in triggering diabetes by looking for signs of this baggage in the genes of people with diabetes.James Mulvihill: Development of a Noninvasive Blood Glucose Monitor Measuring blood sugar without the blood. For patients with diabetes, keeping close track of their blood sugar means a lifetime of painful needle pricks or an implanted glucose pump. Mulvihill, a former president and CEO of both The Forsyth Institute and the Juvenile Diabetes Research Foundation, wants to know whether it’s possible to develop a blood glucose sensor that works without actually having to break the skin.“My motivation to respond to the challenge came from my knowledge of what an important advance it would be in the care of individuals of all ages with both type 1 and type 2 diabetes, if a reliable methodology to monitor blood glucose noninvasively could be developed,” Mulvihill said. “My knowledge comes from having a child who 20 years ago was diagnosed with type 1 diabetes, as well as meeting thousands of individuals with type 1 diabetes and their families.”Dirk Moore: Family-based Association Studies to Identify Gene-Environment Interaction and Genomic Imprinting in Type 1 Diabetes (T1D) Probing the “nature vs. nurture” question. How do genes and environment mix in the development of diabetes? A biostatistician at the University of Medicine and Dentistry of New Jersey, Moore believes that by re-analyzing genetic studies using new statistical techniques, it may be possible to tease apart their relative roles in ways that lead to better tools for controlling or preventing diabetes.“I have taken part in InnoCentive challenges in the past,” said Moore, “and when I saw the Challenge posting, I realized that some of the family-based population study designs that I have worked with in other fields could be applicable to important questions in type I diabetes.”Srinivas Viswanathan: Post-Gastric Bypass Nesidioblastosis as a Model for Understanding Beta-Islet Cell Neogenesis Turning up the volume on beta cell replacement. Why do beta cells undergo an explosive period of growth in the wake of gastric bypass surgery? We don’t know, but Harvard M.D./Ph.D. student Viswanathan thinks this phenomenon could provide new insights into ways of replacing lost beta cells in patients with type 1 diabetes.“I’d not considered doing any work on diabetes before, but happened to be on my surgery rotation at the time the challenge was announced, and at the time I had contact with many patients who had undergone gastric bypass procedures,” said Viswanathan. “I was intrigued by the observation that many of these patients were no longer diabetic after having the surgery, and read about this phenomenon wherein gastric bypass surgery could alter the pancreas’s insulin-producing capacity.”last_img read more

first_img continue reading » Credit union members who were once among the top law enforcement officials in Honolulu face years in federal prison after admitting they defrauded credit unions and banks through elaborate schemes to secure loans that funded their extravagant lifestyle.Last week, former Honolulu Police Chief Louis Kealoha, 59, pleaded guilty to bank fraud, and his wife, Katherine Kealoha, 49, a former Honolulu deputy prosecutor pleaded guilty to bank fraud, aggravated identity theft and drug charges.Plea agreement documents show that the couple spent more than $591,000 derived from loans fraudulently obtained from credit unions and banks, stolen funds from a reverse mortgage scam and money that belonged to two children for whom Mrs. Kealoha was the state court appointed trustee and guardian.The Kealohas used these funds to pay for their personal expenses, including a $26,000 induction brunch when Mr. Kealoha was appointed police chief, car payments for a Maserati and Mercedes Benz, concert tickets, restaurants, hotels and a trip to California’s Disneyland, according federal prosecutors. ShareShareSharePrintMailGooglePinterestDiggRedditStumbleuponDeliciousBufferTumblrlast_img read more

first_imgOptimism seems to be back in the UK North Sea oil and gas industry, as a recent study showed local firms now being equally “optimistic about the North Sea and international markets for the first time since 2013.”According to an oil and gas industry survey conducted by Aberdeen & Grampian Chamber of Commerce in partnership with the Fraser of Allander Institute and KPMG, while firms have in recent years looked to international markets for business growth, business confidence is returning to the UKCS in terms of its potential future prosperity.In the survey, overall almost two thirds (64%) of contractors are more confident about doing business than they were a year ago with only 8% indicated being less confident. This net balance of plus 56% is greater than the plus 39% recorded in the previous survey and the highest net balance recorded since spring 2013. Going forward, seven in 10 contractors (71%) expect the upward momentum to continue, the survey shows.Exploration “in the black”Accoding to a statement released along the survey results, the trend in the value of UKCS exploration-related work, which has been negative since spring 2014 and dipped to its lowest point in autumn 2016, is finally in the black at a net balance of plus 3%.This is expected to rise to 21% in the next 12 months. The value of international exploration work has, on balance, also been negative since spring 2015 however in this latest survey a net balance of plus 4% of contracting firms indicated an increase, with a net balance of plus 18% expecting a further rise during the coming year, the survey shows.Contractors are also reporting a more positive outlook around production-related work in the UKCS. For the first time since 2014 firms (a net of plus 20%) have expressed a rise in the value of production activities, with 46% forecasting a further increase in the 12 months ahead.Investments risingThere is further good news when it comes to investment, the survey shows. While 41% of contractors – the highest figure since autumn 2014 – are now working at or above optimum levels in the UKCS, more firms (30%) increased their investment in the region in the last 12 months than those who had reduced their spend (21%). This is a significant shift from the position of two years ago and the trend is expected to continue in the next two years. Operators and licensees, on balance, are also forecasting a rise, suggesting the sector’s own outlook is increasingly positive.The survey looked at work in the six months to March 2018, asking firms about their prospects in the year ahead as well as the next three to five years in order to assess trends in exploration and production, decommissioning and other related oil and gas extraction activities both in the UK and international markets.“It does appear that a corner has been turned but we must avoid complacency”Moray Barber, a partner at KPMG, said: “It is heartening to note the rising confidence the respondents have in the UKCS with nearly three quarters of the firms forecasting an increase in business optimism in the region. Over the last couple of years, the survey has shown us that firms have been more focused on international markets for business growth. However, the latest set of survey results indicates that there is now a rebalancing taking place, with our region becoming just as important again in terms of securing future growth.“Firms are telling us that whilst commodity prices remain an important factor, the extent to which they might hinder growth has lessened significantly. Perhaps this is a sign that firms now consider themselves to be suitably agile in terms of their business structures.“The industry generally continues to be more positive. Recovery in market sentiment is steady but challenges remain in terms of skills shortages and cash flow particularly for SMEs. The survey shows that lengthy payment terms continue to be a problem for SMEs. Against a backdrop of the UK’s new Payment Practices and Performance Reporting (‘PPPR’) regulations and Oil & Gas UK’s Supply Chain Code of Practice, we need to see improvements in this area if the sector as a whole is to flourish.”Job-cut rate slows downThe sector also continued to see a slowdown in the rate of job reduction. According to the survey, while operators are mainly forecasting a reduced slowdown in job reduction, contractors in the supply chain reported a marginal increase (0.2%) in headcount, indicating the recent trend in net job reduction has halted. The survey also showed 70% of firms are forecasting an increase in profits in 2018.Russell Borthwick, chief executive of Aberdeen & Grampian Chamber of Commerce, said: “The oil and gas sector has faced up to some significant and structural challenges over recent years and is beginning to emerge fit for the future. Companies across the eco-system have and continue to adapt and adjust their approach to ensure the industry’s future viability with collaboration and co-operation as well as the implementation of new technology to improve efficiency being cited.“It does appear that a corner has been turned but we must avoid complacency. The future strength of the sector depends on operators, contractors and suppliers continuing to work together in the new way as the climate continues to improve. A steady recovery, not a return to boom and bust is what is required. What is clear is that oil and gas will remain a key contributor to the Scottish and UK economies for many years to come.”last_img read more